Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

KAMADA (KMDA)

  • Event
  • May 17, 2022, 11:05 UTC
  • 13
  • 1 comments

(10% Negative) KAMADA (KMDA) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

KAMADA (KMDA)

  • Event
  • May 17, 2022, 11:00 UTC
  • 13
  • 1 comments

(10% Negative) KAMADA (KMDA) Announces Clinical Development Update (Form 6-K)

Comment Full text

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • May 17, 2022, 11:00 UTC
  • 13
  • 1 comments

(10% Negative) ObsEva SA (company was delisted NASDAQ) (OBSV) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • May 17, 2022, 10:13 UTC
  • 13
  • 1 comments

(30% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

Terns Pharmaceuticals Inc (TERN)

  • Event
  • May 16, 2022, 20:24 UTC
  • 13
  • 1 comments

(30% Negative) Terns Pharmaceuticals, Inc. (TERN) Reports Q2 2022 Financial Results

Comment Full text

Sanofi (SNY)

  • Event
  • May 16, 2022, 17:45 UTC
  • 13
  • 1 comments

(90% Positive) Sanofi (SNY) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • May 16, 2022, 17:00 UTC
  • 14
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

Comment Full text

Inhibrx (INBX)

  • Event
  • May 16, 2022, 13:03 UTC
  • 14
  • 1 comments

(90% Positive) INHIBRX, INC. (INBX) Announces Clinical Development Update

Comment Full text

Repare Therapeutics Inc (RPTX)

  • Event
  • May 16, 2022, 12:42 UTC
  • 14
  • 1 comments

(99% Neutral) Repare Therapeutics Inc. (RPTX) Announces New Board Appointment

Comment Full text

Cellectis (CLLS)

  • Event
  • May 16, 2022, 12:15 UTC
  • 13
  • 1 comments

(30% Negative) Cellectis (CLLS) Files Form 6-K

Comment Full text
  • Previous
  • 380
  • 381
  • 382
  • 383
  • 384
  • Next

Search

News categories

  • Technical Exchange News(11639)
  • Event(3907)
  • SEC News(228333)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(140712)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin